Literature DB >> 15196279

The expression of stem cell factor and c-kit receptor in human asthmatic airways.

S Z Al-Muhsen1, G Shablovsky, R Olivenstein, B Mazer, Q Hamid.   

Abstract

BACKGROUND: Asthmatic airways are characterized by infiltration with a variety of inflammatory cells such as mast cells and eosinophils. Stem cell factor (SCF) is an important activating and chemotactic factor for both mast cells and eosinophils. In addition, it is a critical growth and differentiation factor for mast cells.
OBJECTIVES: To investigate the contribution of SCF to the pathogenesis of asthma, we examined the expression of SCF and its receptor c-kit in bronchial biopsies and bronchoalveolar lavage (BAL) specimens obtained from asthmatic subjects (n=13) and non-asthmatic control subjects (n=10).
METHODS: SCF and c-kit were detected by in situ hybridization (ISH) and immunocytochemistry (ICC). In order to phenotype the cells expressing SCF and c-kit in asthmatic tissue and BAL cells, combined ISH and ICC were also performed.
RESULTS: There was a significant difference (P<0.001) in the SCF mRNA expression in asthmatic airway epithelium (70.38+/-12.33% positive cells) compared with controls (12.7+/-17.21% positive cells). There was also a significant difference in subepithelial SCF-mRNA expression, being higher in asthmatics (P<0.001). A significant difference was also found in c-kit receptor mRNA expression in asthmatic biopsies both in epithelium (P<0.001) and subepithelium (P<0.05) compared with controls. ICC results were consistent with the ISH for both SCF and c-kit receptor from asthmatics and controls. The SCF and c-kit receptor mRNA and immunoreactivity in cells recovered from bronchial washing were also significantly higher in asthmatics compared with controls (P<0.05). While SCF expression was localized predominantly in the epithelial layer in bronchial biopsy tissues, alveolar macrophages were found to be the major source of SCF in bronchial washing from asthmatic subjects.
CONCLUSION: The results of this study demonstrate the increased expression of SCF and its receptor, c-kit within human asthmatic airways, which suggests an important role of this cytokine in the pathophysiology of asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196279     DOI: 10.1111/j.1365-2222.2004.01975.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  22 in total

1.  Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.

Authors:  F H Hsieh; P Sharma; A Gibbons; T Goggans; S C Erzurum; S J Haque
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

2.  Secretoglobin Superfamily Protein SCGB3A2 Alleviates House Dust Mite-Induced Allergic Airway Inflammation in Mice.

Authors:  Mitsuhiro Yoneda; Lei Xu; Hiroaki Kajiyama; Shuko Kawabe; Jorge Paiz; Jerrold M Ward; Shioko Kimura
Journal:  Int Arch Allergy Immunol       Date:  2016-11-08       Impact factor: 2.749

3.  Intranasal sirna targeting c-kit reduces airway inflammation in experimental allergic asthma.

Authors:  Wei Wu; Hui Chen; Ya-Ming Li; Sheng-Yu Wang; Xin Diao; Kai-Ge Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Stem cell-related proteins C-KIT, C-MYC and BMI-1 in juvenile nasopharyngeal angiofibroma--do they have a role?

Authors:  Suvi Renkonen; Valtteri Häyry; Päivi Heikkilä; Ilmo Leivo; Caj Haglund; Antti A Mäkitie; Jaana Hagström
Journal:  Virchows Arch       Date:  2010-11-27       Impact factor: 4.064

5.  Role of stem cell factor and bone marrow-derived fibroblasts in airway remodeling.

Authors:  Vladislav A Dolgachev; Matthew R Ullenbruch; Nicholas W Lukacs; Sem H Phan
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

6.  Eosinophil activation of fibroblasts from chronic allergen-induced disease utilizes stem cell factor for phenotypic changes.

Authors:  Vladislav Dolgachev; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

Review 7.  Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms.

Authors:  Glenn Cruse; Dean D Metcalfe; Ana Olivera
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-12       Impact factor: 3.479

Review 8.  Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

Authors:  B M Jensen; C Akin; A M Gilfillan
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

9.  SHP2 phosphatase promotes mast cell chemotaxis toward stem cell factor via enhancing activation of the Lyn/Vav/Rac signaling axis.

Authors:  Namit Sharma; Stephanie Everingham; Baskar Ramdas; Reuben Kapur; Andrew W B Craig
Journal:  J Immunol       Date:  2014-04-14       Impact factor: 5.422

10.  Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity.

Authors:  Joanna S Makowska; Malgorzata Cieslak; Marek L Kowalski
Journal:  BMC Pulm Med       Date:  2009-06-01       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.